# EDGAR Filing Document

**Accession Number:** 0000895665
**File Stem:** 0001493152-23-010376
**Filing Date:** 2023-3
**Character Count:** 6648
**Document Hash:** 0f755e21a6de5a258ee8e4ee317ae770
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-010376.hdr.sgml**: 20230331

**ACCESSION NUMBER**: 0001493152-23-010376

**CONFORMED SUBMISSION TYPE**: NT 10-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230331

**DATE AS OF CHANGE**: 20230331

**EFFECTIVENESS DATE**: 20230331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Clearday, Inc.
- **CENTRAL INDEX KEY:** 0000895665
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-NURSING & PERSONAL CARE FACILITIES [8050]
- **IRS NUMBER:** 770158076
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NT 10-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-21074
- **FILM NUMBER:** 23788884

**BUSINESS ADDRESS:**
- **STREET 1:** 15511 W. STATE HWY 71
- **STREET 2:** SUITE 110-105
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78738
- **BUSINESS PHONE:** 512-650-7775

**MAIL ADDRESS:**
- **STREET 1:** 15511 W. STATE HWY 71
- **STREET 2:** SUITE 110-105
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78738

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SUPERCONDUCTOR TECHNOLOGIES INC
- **DATE OF NAME CHANGE:** 19940214

---

| | | |
|:---|:---|:---|
|  | **OMB APPROVAL** | **OMB APPROVAL** |
| **UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION** **<br> Washington, D.C. 20549**<br>**FORM 12b-25** | OMB Number: | 3235-0058 |
| **UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION** **<br> Washington, D.C. 20549**<br>**FORM 12b-25** | Expires: | February 28, 2022 |
| **UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION** **<br> Washington, D.C. 20549**<br>**FORM 12b-25** | Estimated average burden hours per response. | 2.50 |

---

---

| | |
|:---|:---|
| | SEC FILE NUMBER<br>000-21074 |
|  | CUSIP NUMBER |
| **NOTIFICATION OF LATE FILING** | 184791 101 |

---

*(Check one):* ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D <br> ☐ Form N-CEN ☐ Form N-CSR

---

| |
|:---|
| For Period Ended: <u>December</u> <u>31, 2022</u><br> ☐ Transition Report on Form 10-K<br> ☐ Transition Report on Form 20-F<br> ☐ Transition Report on Form 11-K<br> ☐ Transition Report on Form 10-Q |
| For the Transition Period Ended: ____________________ |

---

*Read Instruction (on back page) Before Preparing Form. Please Print or Type.* <br> **Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.**

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

**PART I — REGISTRANT INFORMATION**

---

| |
|:---|
| Clearday, Inc. |
| Full Name of Registrant |
| N/A |
| Former Name if Applicable |
| 8800 Village Drive, Suite 106 |
| Address of Principal Executive Office *(Street and Number)* |
| San Antonio, Texas 78217 |
| City, State and Zip Code |

---

**PART II — RULES 12b-25(b) AND (c)**

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

---

| | |
|:---|:---|
| X (a) | The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
| X (b) | The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and |
| (c) | The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |

---

**PART III — NARRATIVE**

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period. (Attach extra Sheets if Needed)

The Company is in the process of preparing and reviewing the financial and other information for its Form 10-K report for the annual period ended December 31, 2022, and does not expect the report will be finalized for filing by the prescribed due date without unreasonable effort or expense. The Company needs additional time to complete its financial statements and assess events subsequent to December 31, 2022 that require disclosure in the Form 10-K and such financial statements. The Company undertakes the responsibility to file such report no later than fifteen days following the prescribed due date.

**PART IV — OTHER INFORMATION**

(1) Name and telephone number of person to contact in regard
 to this notification

<u>James T. Walesa</u> <u> 210</u> <u>451-0839 </u> <br> (Name) (Area Code) (Telephone Number)

(2) Have all other periodic
 reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of
 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed?
 If answer is no, identify report(s).

Yes ☒ NO ☐

(3) Is it anticipated that
 any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings
 statements to be included in the subject report or portion thereof?

Yes ☐ NO ☒

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

Clearday, Inc.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| Date: | March 31, 2023 | By: | */s/ James T. Walesa* |
|  |  | Name: | James T. Walesa |
|  |  | Title: | Chief Executive Officer |

---

INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative's authority to sign on behalf of the registrant shall be filed with the form.

**ATTENTION<br> Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).**